Page 47 - 87_02

ANALES
RANF
www.analesranf.com
GPR43: Receptor acoplado a la proteína G43
IL-10: Interleukina 10.
IL-6: Interleukina 6.
MPO: Mieloperoxidasa.
NFkb: Factor nuclear de transcripción kappa-beta.
NOS: Radicales del nitrógeno
RAGE: Receptor para los compuestos avanzados de glicosilación
ROS: Radicales del oxígenos
SCFA: Ácidos grasos de cadena corta
SIM: Single Ion Monitoring.
sRAGE: Fracción soluble del receptor RAGE
TNFa: Factor de necrosis tumoral alfa.
5. REFERENCIAS
1. Royero HA. Enfermedad inflamatoria intestinal. Revista Colombiana
de Gastroenterología. 2003, 18(1): 20-6.
2. Fiocchi C. Inflammatory bowel disease: aetiology and pathogenesis.
Gastroenterology. 1998, 115: 182–205.
3. Farrell RJ, Peppercorn MA. Ulcerative colitis. The Lancet. 2002, 359:
331–40.
4. Sartor RB. Pathogenesis and immune mechanisms of chronic in-
flammatory bowel diseases. American Journal of Gastroenterology.
1997, 92: 5S–11S.
5. Mills DJS, Tuohy KM, Booth J, Buck M, Crabbe MJC, Gibson GR, Ames
JM. Dietary glycated protein modulates the colonic microbiota to-
wards a more detrimental composition in ulcerative colitis patients
and non-ulcerative colitis subjects. Journal of Applied Microbiology.
2008, 105: 706–14.
6. Higa A, McKnight W, Wallace JL. Attenuation of epithelial injury in
acute experimental colitis by immunomodulators. European Journal
of Pharmacology. 1993, 239: 171–76.
7. MacDermott RP. Alterations of the mucosal immune system in in-
flammatory bowel disease. Journal of Gastroenterology. 1996, 31:
907–16.
8. Mortensen PB, Clausen MR. Short-chain fatty acids in the human
colon: relation to gastrointestinal health and disease. Scandinavian
Journal of Gastroenterology. 1996, 31: 132S–48S.
9. Karaki S, Mitsui R, Hayashi H, Kato I, Sugiva H, Iwanaga T, Furnes
JB, Kuwahara A. Short-chain fatty acid receptor, GPR43, is expressed
by enteroendocrine cells and mucosal mast cells in rat intestine. Cell
Tissue Research. 2006, 324: 353–60.
10. Sina C, Gavrilova O, Förster M, Till A, Derer S, Hildebrand F, Raabe
B, Chalaris A, Scheller J, Rehmann A, Franke A, Ott S, Häsler R, Ni-
kolau S., Fölsch UR, Rose-John S, Jiang HP, Li J, Schreiber S, Ro-
senstiel P. G protein-coupled receptor 43 is essential for neutrophil
recruitment during intestinal inflammation. Journal of Immunology.
2009, 183: 7514-22.
11. Chadwick VS, Anderson RP. Inflammatory Products of Commensal
Bacteria and Gastro-Intestinal Disorders. Digestive Diseases. 1990,
Regulación de la respuesta inflamatoria intestinal mediante la ingesta de
compuestos de Maillard y su interacción con los receptores RAGE y GPR43
Silvia Pastoriza y José Ángel Rufián-Henares
An. Real Acad. Farm. Vol. 87. NÀ 2 (2021) · pp. 141 - 154
8: 253–68.
12. Reif S, Klein I, Lubin M. Pre-illness dietary factors in inflammatory
bowel disease. Gut. 1997, 40: 754-60.
13. Jowett SL, Seal CJ, Pearce MS, Phillips E, Gregory W, Barton JR,
Welfare MR. Influence of dietary factors on the clinical course of ul-
cerative colitis: a prospective cohort study. Gut. 2004, 53:1479–
84.
14. Serra-Majem L, Ribas L, Ngo de la Cruz J, Ortega RM. Alimentación,
jóvenes y dieta mediterránea en España. Desarrollo del KIDMED, ín-
dice de calidad de la dieta mediterránea en la infancia y adoles-
cencia, En: Serra Majem L, Aranceta Bartrina J. (Eds.), Alimentación
infantil y juvenil, Estudio Enkid Masson, Barcelona, España, 2002,
pp. 51-59.
15. Seiquer I, Mesías M, Muñoz-Hoyos A, Galdó G, Navarro MP. Medi-
terranean Dietary Style Improves Calcium Utilization in Healthy Male
Adolescents. Journal of the American College of Nutrition. 2008,
27: 454-62.
16. Rufián-Henares JA, Morales FJ. Functional properties of melanoidins:
In vitro antioxidant, antimicrobial and antihypertensive activities.
Food Research International. 2007, 40: 995-1002.
17. Nass N, Bartling B, Navarrete-Santos A, Scheubel R, Börgermann
J, Silber RE, Simm A. Advanced glycation end products, diabetes
and ageing. Zeitung Gerontology Geriatrics. 2007, 40: 349–56.
18. Yamagishi S, Takeuchi M, Inagaki Y, Nakamura K, Imaizumi T. Role
of advanced glycation end products (AGEs) and their receptor (RAGE)
in the pathogenesis of diabetic microangiopathy. International Jour-
nal of Clinical Pharmacology Research. 2003, 23:129-34.
19. Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B,
Stern DM, Nawroth PP. Understanding RAGE, the receptor for ad-
vanced glycation end products. Journal of Molecular Medicine. 2005,
83: 876–86.
20. Raman, KG, Sappington PL, Ryan RY, Levy M. Prince JM, Liu S, Wat-
kins SK, Schmidt AM, Billiar TR, Fink MP. The role of RAGE in the
pathogenesis of intestinal barrier dysfunction after haemorrhagic
shock. American Journal of Physiology and Gastrointestinal Liver
Physiology. 2006, 291: G556–65.
21. Collison KS, Parhar RS, Saleh SS, Meyer BF, Kwaasi AA, Hammami
MM, Schmidt AM, Stern DM, Al-Mohanna FA. RAGE-mediated neu-
trophil dysfunction is evoked by advanced glycation end products
(AGEs). Journal of Leukocyte Biology. 2002, 71: 433-44.
22. Kislinger T, Fu C, Huber B, Qu W, Taguchi A, Du-Yan S. N(epsilon)-
(carboxymethyl)lysine adducts of proteins are ligands for RAGE that
activate cell signaling pathways and modulate gene expression.
Journal of Biological Chemistry. 1999, 274: 31740–9.
23. Valencia JV, Weldon SC, Quinn D, Kiers GH. Advanced glycation end
product ligands for the receptor for advanced glycation end products:
biochemical characterization and formation kinetics. Analytical Bio-
chemistry. 2004, 324: 68–78.
24. Charissou A, Ait-Ameur L, Birlouez-Aragon I. Evaluation of a gas
153